| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |